Saturday, 31 October 2026European Markets

SCANA Stock Jumps By 32% In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of SCANA (Oslo Børs All-share Index_GI: SCANA.OL) jumped by a staggering 32.33% in 21 sessions from $1.06 to $1.40 at 13:53 EST on Monday, after three consecutive sessions in a row of losses. Oslo Børs All-share Index_GI is dropping 0.89% to $1,365.78, after sequential sessions in a row of losses.

SCANA's last close was $1.36, 24.58% under its 52-week high of $1.80.

About SCANA

Scana ASA provides equipment and services to the maritime industry. The company offers valve remote control systems and mooring solutions to vessels, rigs, and floating structures serving the shipping, oil and gas, aquaculture, and energy industries. It also engages in the design and integration of electrical power systems, electrical infrastructure, and energy storage systems and control systems; and provides standard and customized containers/module solutions, as well as various types of welded constructions for offshore and onshore projects. In addition, the company is involved in the planning and execution of insulation, scaffolding, and surface treatment services; and rig, capping, equipment support, make and break, IMR lifecycle, welding, and asset integrity management services to drilling industry, as well as offers riser applications to the oil and gas industry. The company was formerly known as Incus Investor ASA and changed its name to Scana ASA in May 2020. Scana ASA was founded in 1646 and is headquartered in Bergen, Norway.

Earnings Per Share

As for profitability, SCANA has a trailing twelve months EPS of $0.43.

PE Ratio

SCANA has a trailing twelve months price to earnings ratio of 3.25. Meaning, the purchaser of the share is investing $3.25 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -8.35%.

More news about SCANA (SCANA.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com